The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics
Anna Meta Dyrvig Kristensen(Frederiksberg Hospital), Dan Atar, T S G Sehested(Copenhagen University Hospital), Michael Hecht Olsen, Sigrun Halvorsen, Theis Lange(Aalborg University), Vidar Ruddox(Sykehuset i Vestfold), Christian Torp‐Pedersen(Gentofte Hospital), Eva Prescott(Frederiksberg Hospital), Arnhild Bakken(Oslo University Hospital), John Munkhaugen(University of Oslo), Morten Wang Fagerland(Oslo University Hospital)
Cited by 21
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
|New England Journal of Medicine|1995|1.8k
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
|New England Journal of Medicine|2016|1.7k